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BR2BodPR2: highly fluorescent alternatives to PPh3
and PhPCy2†
Laura H. Davies, Ross W. Harrington, William Clegg and Lee J. Higham*
The syntheses of highly fluorescent analogues of PPh3 and PhPCy2 based on the Bodipy chromophore
are described. The ligands have been incorporated into two- to four-coordinate group 11 metal com-
plexes. The synthesis, characterisation and photophysical properties of the novel ligands and their metal
complexes are reported; many of these compounds have also been characterised by single-crystal X-ray
diffraction. Incorporation of the phosphino group and complexation to the group 11 metal centre has
little effect on the absorption and emission profiles; high molar extinction coefficients and fluorescence
quantum yields were still obtained. In particular, incorporation of the dicyclohexylphosphino substituent
significantly increases the quantum yields relative to the parent dyes.
Introduction
Metal complexes of fluorescent phosphines have potential
applications in diagnostic cell imaging1 and catalytic reaction
monitoring,2 by virtue of the sensitivity of the fluorescence
technique. As an imaging tool used in vitro, fluorescence
microscopy produces high spatial resolution of the nanometre
order, giving accurate images of processes at the subcellular
level;1,3 there is current interest in incorporating fluorescent
tags onto radiopharmaceuticals, because it is otherwise
difficult to image the localisation of such probes in detail.
A fluorescent radiopharmaceutical would instead facilitate
both in vivo and in vitro imaging,3 allowing one to gain a
better understanding of the probe’s mechanism and localis-
ation within cells. The sensitivity of fluorescence spectroscopy
compared to its NMR counterpart (10−6 to 10−7 M), also sig-
nifies that the detection of low concentrations of catalytically
active species – undetectable by other means – ought to also
be possible.2 However, phosphines conjugated to organic
fluorophores often suffer from fluorescence quenching4 due to
reductive photoinduced electron transfer, therefore synthetic
routes to this class of compound have not been extensively
reported and fluorescent phosphines remain somewhat rare.5
F-Bodipy has desirable photophysical properties which
include a high fluorescence quantum yield, strong UV-absorp-
tion, chemical robustness and good solubility (Fig. 1).6 A
common site of modification is at the meso position due to its
easy synthetic incorporation.6 Over the last few years new syn-
thetic procedures have been developed for the substitution of
the fluorides with aryl/alkyl (C-Bodipy) or ethynyl (E-Bodipy)
groups; this development has allowed more sophisticated
functions to be introduced on the Bodipy backbone.6 Given
the desirable properties of Bodipy and the extensive synthetic
routes to derivatives,6 we aimed to create fluorescent tertiary
phosphines based on this versatile fluorophore, coordi-
nate the new ligands to transition metals and study their
behaviour.
Group 11 metal phosphine complexes are sought after, in
part, due to their known medicinal applications.7 Gold(I),8
silver(I)9 and copper(I)10 phosphine complexes have all shown
cytotoxic activity, with significant anti-tumour properties –
current complexes are based on monodentate and bidentate
phosphines. One breakthrough was the discovery of auranofin
(Fig. 1) in the early 1980s by Sutton,11 a gold(I) phosphine
complex, that was approved for clinical use in 1985 to treat
rheumatoid arthritis, but which has also been shown to
exhibit anticancer properties,12 and led to the development of
several two-coordinate gold(I) phosphine analogues.8
Fig. 1 F-Bodipy (I) and auranofin (II).
†Electronic supplementary information (ESI) available: Experimental methods,
spectroscopic and crystallographic characterisation, photophysical measure-
ments and molecular modelling details. CCDC 987389, 987388, 987387, 987386,
987385, 987390, 987384, 987391, 987383 and 987382. For ESI and crystallo-
graphic data in CIF or other electronic format see DOI: 10.1039/c4dt00704b
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To further develop the possibility of using gold-based drugs,
a greater knowledge of their subcellular distribution and
mechanism of action is desirable – a fluorescent gold phos-
phine complex could help to understand the biodistribution of
such compounds at high resolution and precision.1,3 Both
gold and silver also have potential in therapeutic nuclear medi-
cine due to the beta-emitting radioisotopes 199Au and 111Ag,
which have long half-lives of 3.15 and 7.5 days respectively.13
Copper has a range of radionuclides, but the most commonly
investigated is 64Cu – a positron emitter – and thus can be
used for diagnostic nuclear medicine purposes in Positron
Emission Tomography (PET) imaging; its relatively long half-
life of 762 minutes is considered attractive.14 For the afore-
mentioned reasons it would therefore be interesting to
investigate the coordination chemistry of novel fluorescent
monodentate phosphines with the group 11 metals and
measure the photophysical properties of any complexes so syn-
thesised, to ascertain if they are suitable for study in the appli-
cations already discussed above.
Results and discussion
Synthesis of Bodipy monodentate phosphines
Scheme 1 details our synthesis of the four novel Bodipy mono-
dentate tertiary phosphines 2a/2b and 3a/3b, substituted at
the meso position; aryl bromides 1a and 1b15 were lithiated by
reacting with n-butyllithium in diethyl ether at −78 °C to room
temperature, followed by the addition of chlorodiphenyl-
phosphine or chlorodicyclohexylphosphine. Both aryl- and
alkylchlorophosphines reacted in a similar manner and we
also found that the substituent at the boron atom had a
limited effect on the overall reactivity of the aryl bromide; all
four ligands were produced in good yields ranging from 60 to
84%. The route thus depicts a mild synthetic method for
preparing phosphines containing a Bodipy fluorophore.
The 31P{1H} NMR spectra of the triarylphosphines in
d-chloroform showed 2a/2b at δ −5.5 ppm; aryldialkyl-
phosphines 3a and 3b are shifted downfield to δ 2.7 and 2.8 ppm
respectively, due to the electron-donating cyclohexyl rings.
Crystals of 2a were analysed by X-ray crystallography and its
molecular structure is depicted in Fig. 2; similar atom number-
ing schemes are used for all the crystal structures. The P–C
bond lengths of 1.8302(19), 1.834(2) and 1.827(2) Å and C–P–C
bond angles of 104.03(9), 101.66(9) and 102.40(9)° are
typical for tertiary phosphines and compare well to
triphenylphosphine.16
Coordination chemistry
Copper. Tetrakis(acetonitrile)copper(I) hexafluorophosphate
was treated with two equivalents of 2a/2b or 3a/3b in dichloro-
methane which led to the formation of [Cu(2a/2b)2(CH3CN)]-
[PF6] (4a/4b) and [Cu(3a/3b)2(CH3CN)][PF6] (5a/5b), as depicted
in Scheme 2; two phosphines coordinate to the copper(I)
centre, replacing the labile acetonitrile ligands. Coordination
of the phosphines causes a broadening and downfield shift of
the 31P{1H} NMR signal from δ −5.5, and 2.7/2.8 ppm for the
free phosphines 2a/2b and 3a/3b to δ 0.0/0.1, and 13.4/12.7 ppm
for the complexes 4a/4b and 5a/5b respectively – these values
compare well to other copper(I) acetonitrile phosphine com-
plexes.17,18 Crystals of 4a and 4b suitable for X-ray crystallography
were obtained by slow diffusion from ethanol/pentane; the mole-
cular structure of 4b is depicted in Fig. 3, whilst the structure
of a compound obtained from the attempted recrystallization
of 4a is given in the ESI.† Complex 4b contains a three-coordi-
nate copper(I) centre with a non-coordinating PF6
− anion and
one ethanol molecule, which has exchanged for the labile
acetonitrile ligand, coordinated to the copper centre.
The Cu–P bond lengths of 2.2384(11) and 2.2273(11) Å are
typical for copper(I) complexes.18,19 The complex has a dis-
Scheme 1 Synthesis of the C-Bodipy substituted tertiary phosphine
derivatives.
Fig. 2 Molecular structure of 2a with 30% probability displacement
ellipsoids (as in other figures). Hydrogen atoms have been omitted for
clarity. Selected bond distances [Å] and angles [°]: P–C21 1.8302(19),
P–C24 1.834(2), P–C30 1.827(2), C4–C5 1.395(3), N1–C4 1.400(2), N1–B
1.568(2), B–C36 1.626(3); C21–P–C24 101.66(9), C21–P–C30 104.03(9),
C24–P–C30 102.40(9), C4–C5–C6 122.44(16), B–N1–C4 123.14(15),
N1–B–C36 107.65(15), N1–B–N2 105.17(15).
Scheme 2 Synthesis of copper(I) complexes 4a/4b and 5a/5b.
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torted trigonal planar geometry for copper, shown by the
P1–Cu–P2, P1–Cu–O5 and P2–Cu–O5 bond angles of
130.49(4)°, 113.61(9)° and 115.43(9)° respectively; both the
phosphorus atoms are slightly tilted towards the ethanol mole-
cule. The anion⋯Cu(I) interaction is weak as signified by the
closest Cu⋯F distance of 3.156 Å. The analogous reaction of a
2 : 1 ratio of triphenylphosphine and [Cu(CH3CN)4][PF6]
resulted in the distorted four-coordinate tetrahedral complex
[Cu(PPh3)2(CH3CN)2].
17,20 Ligand 2b is sterically more bulky
than triphenylphosphine, and therefore the four-coordinate
structure may be too crowded for the first-row d10 transition
metal in this case.
Complex 5a was crystallised by slow solvent diffusion
(chloroform–diethyl ether); two types of crystals were produced
and their molecular structures are shown in Fig. 4. Structure A
is a three-coordinate copper(I) complex with two phosphines
and one acetonitrile ligand coordinated to the copper centre,
and a non-coordinating anion, PF6
−. The Cu–P bond lengths
of 2.2273(11) and 2.2564(10) Å are typical of copper(I) phos-
phine complexes.18,19 The complex has a distorted trigonal
planar geometry as shown by the P1–Cu–P2, P1–Cu–N5 and
P2–Cu–N5 bond angles of 136.11(4)°, 120.68(10)° and
102.36(10)° respectively; the P1–Cu–P2 angle is larger than in
complex 4b due to the steric bulk of the cyclohexyl groups. The
anion⋯Cu(I) interaction is again weak, as signified by the
closest Cu⋯F distance of 3.228 Å. Structure B is a distorted tri-
gonal-planar copper(I) complex with two phosphines co-
ordinated and no bound acetonitrile ligands, but the PF6
−
anion (modelled with disorder) is weakly coordinated to the
copper centre as shown by a stronger anion⋯Cu(I) interaction
than in structure A; the alternative closest Cu⋯F distances are
2.741(7) Å to F6A as shown in Fig. 4, and 2.964(11) Å to F6B
(not shown); F6A is disordered over two symmetry-related posi-
tions in the trigonal plane with the copper centre (on a twofold
rotation axis) and two P atoms. All other Cu⋯F distances are
>4 Å and are thus non-bonded. A search of the Cambridge
Structural Database21 reveals 11 structures recorded with
weakly coordinated PF6
− and BF4
− anions having Cu⋯F >
2.7 Å.22 The P–Cu–P bond angle of 149.98(9)° is large for a
three-coordinate structure but is consistent with the steric
bulk of the cyclohexyl groups and is similar to that in the
three-coordinate complex [Cu(PCy3)2(ClO4)], which has a
P–Cu–P angle of 144.46(6)°.23 The symmetry-equivalent Cu–P
bonds lengths of 2.2280(15) Å are typical and compare well
with [Cu(PCy3)2][PF6], which was prepared by Che et al.
18 In
that complex the crystal structure reveals a two-coordinate
linear copper(I) structure, with Cu–P bond lengths of 2.213(1)
and 2.313(1) Å, and a much larger P–Cu–P angle of 179.47(3)°,
consistent with a linear geometry and ionic PF6
−.18 However,
when the counter-ions tetrafluoroborate and perchlorate were
employed, three-coordinate structures were obtained (similar
to 5a, structure B) with copper–fluorine and copper–oxygen
distances of 2.420(6) and 2.220(7) Å and P–Cu–P angles of
159.98(8)° and 144.46(6)° respectively.23,24 Willet et al. showed
Fig. 3 View of the molecular structure of 4b with selected atom labels.
Hydrogen atoms bound to carbon have been omitted for clarity.
Selected bond distances [Å] and angles [°]: Cu–P1 2.2384(11), Cu–P2
2.2273(11), Cu–O5 2.063(3), P1–C23 1.824(4), P1–C26 1.821(4), P1–C32
1.831(4), O5–C75 1.409(5); P1–Cu–P2 130.49(4), P1–Cu–O5 113.61(9),
P2–Cu–O5 115.43(9).
Fig. 4 View of the molecular structures of 5a structure A (top) and 5a
structure B (bottom). Hydrogen atoms have been omitted for clarity.
Selected bond distances [Å] and angles [°]: 5a structure A – Cu–P1
2.2273(11), Cu–P2 2.2564(10), Cu–N5 1.994(3), P1–C33 1.829(4),
P1–C42 1.841(4), P2–C83 1.845(4), N5–C95 1.128(5), C95–C96 1.466(6);
P1–Cu–P2 136.11(4), P1–Cu–N5 120.68(10), P2–Cu–N5 102.36(10),
C83–P2–C89 107.56(16), C80–P2–C83 101.98(15), Cu–P2–C83
110.59(12), Cu–P2–C80 122.24(12). 5a structure B – Cu–P1 2.2280(15),
P1–C33 1.819(4), P1–C36 1.866(5), P1–C42 1.867(5), Cu⋯F6A 2.741;
P1–Cu–P1’ 149.98(9), Cu–P1–C33 121.92(17), Cu–P1–C36 111.55(16),
C33–P1–C36 102.6(2).
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that dicyclohexylphenylphosphine (which is the closest ana-
logue to 3a and 3b) produced [Cu(PCy2Ph)2][ClO4] with the per-
chlorate anion, but with tetrafluoroborate a different copper(I)
complex formed, [Cu(PCy2Ph)2(F–BF3)]. Currently the crystal
structures are not known to confirm whether the counter-ions
have any significant coordinating interaction.25
Silver. Treatment of a dichloromethane solution of (1,5-
cyclooctadiene)hexafluoroacetylacetonatosilver(I) ([Ag(η2:η2-
cod)(hfa)]) with two equivalents of 2a/2b or 3a/3b led to the
formation of the neutral silver(I) complexes [Ag(2a/2b)2(hfa)]
(6a and 6b) and [Ag(3a/3b)2(hfa)] (7a and 7b), as depicted in
Scheme 3. Two phosphines coordinate to the silver, displacing
the labile 1,5-cyclooctadiene, to give the products in nearly
quantitative yields. Silver has two NMR-active isotopes, 107Ag
(I = 1/2, natural abundance 52%) and 109Ag (I = 1/2, natural
abundance 48%), therefore the expected 31P{1H} NMR spectra
for 6a/6b and 7a/7b would consist of two doublets arising from
107Ag–P and 109Ag–P spin–spin coupling.26
Phosphine coordination resulted in a downfield shift of the
31P{1H} NMR signal at room temperature from δ −5.5 ppm for
the free phosphines 2a/2b to broad peaks at δ 10.2 and 6.6 ppm
for the complexes 6a and 6b respectively (Fig. 5 and ESI†); the
signal was a broad singlet at elevated temperatures in both
cases, which likely results from rapid phosphine exchange.26
This lability is reduced at low temperatures and the Ag–P coup-
ling can be observed.26
At low temperature (−40 °C) two doublets appeared; 1J107AgP
= 444 Hz and 1J109AgP = 511 Hz, and
1J107AgP = 446 Hz and
1J109AgP = 507 Hz coupling constants were observed for 6a and
6b respectively; these values are typical for silver(I) complexes
with two phosphines bound26,27 and compare well to [Ag-
(PEt3)2(hfa)] (
1J107AgP = 468 Hz).
28 For both 6a and 6b a second
set of two low-intensity doublets was observed at −40 °C and
indicates that a second silver species was present in solution.
For these signals the following Ag–P couplings were measured:
1J107AgP = 696 Hz and
1J109AgP = 803 Hz, and
1J107AgP = 590 Hz
and 1J109AgP = 677 Hz for 6a and 6b respectively. The increase
in Ag–P coupling constants indicates a change in the hybridis-
ation state of the silver(I) complex26,27 and is attributed to [Ag-
(2a/2b)(hfa)] with only one phosphine ligand bound. The coup-
ling constants are similar to the reported values for [Ag(PR3)-
(hfa)] (R = Ph, Me, Et): 1J107AgP = 700–760 Hz.
28,29
Puddephatt et al. reported that an equilibrium is estab-
lished on the addition of excess phosphine to [Ag(PR3)(hfa)]
complexes and showed that the Ag–hfa bonding is more ionic
when extra phosphines are present.28,30 Mass spectrometry
confirmed the [Ag(2a/2b)2]
+ product, giving peaks at m/z of
1469.6056 (6a) and 1217.5443 (6b), with loss of the hfa ligand.
Low-intensity peaks at 786.2561 and 663.2251 were also
observed, which correspond to [Ag(2a/2b)]+, in addition to
peaks at 2148.9477 and 1777.8560 for the tris-cations [Ag(113a/
113b)3]
+, but these latter species were not detected by NMR
spectroscopy.
On coordination of the dicyclohexyl phosphines 3a and 3b
the 31P{1H} NMR signals at room temperature were also shifted
downfield for the complexes 7a and 7b; however, instead of a
broad singlet, two broadened doublets were observed at
δ 23.7 ppm and δ 23.9 ppm for 7a and 7b respectively (Fig. 6
and ESI†). The following Ag–P coupling constants were observed
for 7a and 7b respectively: 1J107AgP = 453 Hz and
1J109AgP =
517 Hz, and 1J107AgP = 453 Hz and
1J109AgP = 519 Hz. At higher
temperatures (120 °C) 7a and 7b gave a broad singlet.
Scheme 3 Synthesis of the silver(I) complexes 6a/6b and 7a/7b.
Fig. 5 31P{1H} VT NMR of [Ag(2b)2(hfa)] 6b, in d8-toluene.
Fig. 6 31P{1H} VT NMR of [Ag(3b)2(hfa)] 7b, in d10-o-xylene.
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The observation of Ag–P coupling at room temperature was
unusual since the rapid exchange of the phosphine ligands
usually causes this coupling to be averaged to zero; this ligand
exchange is normally slowed down by cooling the solution to
low temperatures (as is the case for 6a and 6b).27 However, the
observation of Ag–P coupling at room temperature has been
reported previously, where the phosphine is sterically hindered
or chelating.27,31 Phosphines 3a and 3b are also bulky which
may explain the lower rate of phosphine exchange and the
observation of Ag–P coupling. The electrospray mass spectra
gave peaks for [M − (hfa)]+ at m/z of 1489.7998 for 7a, and
1242.7354 for 7b. Complexes 6a and 7b were also characterised
by X-ray crystallography (Fig. 7). The complexes have neutral
silver(I) tetrahedral four-coordinate geometries with two phos-
phines and one hfa ligand bound to the metal. The Ag–P bond
lengths of 2.4255(10) Å and 2.4028(13) Å are typical for silver(I)
phosphine complexes.25,30,32 The complexes are somewhat dis-
torted, shown by the P–Ag–P, P–Ag–O and O–Ag–O bond
angles (Fig. 7 caption). The synthesis of a related four-coordi-
nate silver(I) complex [Ag(PPh3)2(hfa)] has been reported in a
similar fashion, but currently no crystal structure is known.33
However, the three-coordinate complex [Ag(PPh3)(hfa)] has
had its solid state structure determined – shorter bond lengths
are observed: 2.346(3) for Ag–P, and 2.341(5) and 2.218(5) Å for
Ag–O.29 For 7b the Ag–O bond distances of 2.337(6) Å (Ag–O1)
and 2.718(8) Å (Ag–O2) are significantly different, and the
latter is longer than the normal covalent silver(I)–oxygen bond
length of ca. 2.3 Å, which indicates that the second oxygen is
only weakly bonded to the silver;28 the hfa ligand is disordered
over two positions related by the twofold rotation axis passing
through Ag. The bite angle of the phosphines is larger than in
6a, due to the increased steric bulk of the phosphine 3b. No
β-diketonate silver complexes with dicyclohexylphenyl-
phosphine or tricyclohexylphosphine have been reported,
however cationic two- and three-coordinate silver(I) complexes
do form with dicyclohexylphenylphosphine and the non-coor-
dinating perchlorate, tetrafluoroborate, hexafluorophosphate
and hexafluoroantimonate anions.25,32,33
Gold. Treatment of chloro(tetrahydrothiophene)gold(I) [AuCl-
(tht)] with one equivalent of 2a/2b or 3a/3b in dichloromethane
led to the formation of the neutral gold(I) complexes [AuCl(2a/
2b)] (8a and 8b) and [AuCl(3a/3b)] (9a and 9b), as depicted in
Scheme 4. In each case one phosphine coordinates to the gold,
replacing the labile tht ligand; purification was achieved by
column chromatography, resulting in high yields of 75–91%.
Coordination of the phosphines resulted in a downfield
shift of the 31P{1H} NMR signal of the free phosphines 2a/2b
and 3a/3b to δ 33.2/33.3 and 51.4/51.6 ppm for the complexes
8a/8b and 9a/9b respectively. Complexes 8a, 9a and 9b were
also characterised by X-ray crystallography (Fig. 8 and ESI†).
The solid-state structures show them to be gold(I) two-coordi-
nate linear complexes, as expected.
The Au–P and Au–Cl bond lengths are typical for gold(I)
compounds (Fig. 8 caption).34 The P–Au–Cl bond angles of
177.24(14)°, 178.27(5)° and 177.55(3)° for 8a, 9a and 9b
respectively are close to the ideal 180° for a linear complex.
The analogous complex to 8a/8b, [AuCl(PPh3)], prepared from
triphenylphosphine and chloroauric acid, has a slightly longer
P–Au bond length (2.235(3) Å), and a slightly larger Au–P–Cl
bond angle than 8a (179.68(8)°).34a The analogous dicyclo-
hexylphenylphosphine complex, [AuCl(PCy2Ph)], made from
the ligand and a reaction mixture of tetrachloroauric acid and
2,2′-thiodiethanol, has P–Au and P–Cl bond lengths of 2.234(2)
Fig. 7 Molecular structures of 6a (top) and 7b (bottom). Hydrogen
atoms omitted for clarity. Selected bond distances [Å] and angles [°]:
6a – Ag–P 2.4255(10), Ag–O 2.407(3), P–C33 1.833(4), P–C36 1.824(4),
P–C42 1.825(4), O–C48 1.230(5), C48–C49 1.394(6), C48–C50 1.528(7),
F1–C50 1.281(6), C4–C5 1.394(5); P–Ag–P’ 135.24(5), P–Ag–O
102.34(8), O–Ag–O’ 76.40(15), Ag–P–C33 119.40(13), Ag–P–C36
114.02(13), Ag–P–C42 110.39(13), C33–P–C36 101.79(17), C36–P–C42
103.39(19), Ag–O–C48 129.9(3), O–C48–C49 129.3(5), O–C48–C50
112.9(4), C49–C48–C50 117.8(5). 7b – Ag–P 2.4028(13), Ag–O1 2.337(6),
Ag–O2 2.718(8), P–C21 1.813(5), P–C26 1.826(5), P–C32 1.844(5), O1–
C39 1.231(11), O2–C41 1.233(13), C39–C40 1.392(14), C40–C41 1.403(14),
F1–C38 1.345(16); P–Ag–P’ 141.99(7), P–Ag–O1 112.2(4), O1–Ag–O2
71.93(3), Ag–P–C21 115.98(17), Ag–P–C26 111.93(18), Ag–P–C32
110.70(17), C21–P–C32 103.8(2), C26–P–C32 108.0(3), Ag–O1–C39
135.9(7), O1–C39–C40 132.0(11), O1–C39–C38 111.9(10), C38–C39–C40
115.7(10). Primes denote symmetry-generated atoms. Scheme 4 Synthesis of the gold(I) complexes 8a/8b and 9a/9b.
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and 2.281(3) Å respectively and an Au–P–Cl bond angle of
178.3(1)°, very similar to 9a/9b.34b
Optical properties
After the synthesis of several group 11 metal complexes of
2a/2b and 3a/3b, it was important to determine and under-
stand their photophysical properties. Our initial concern was
whether the phosphorus donor4 or the heavy metals35 them-
selves would quench the fluorescence of the Bodipy fluoro-
phore, which has been shown to occur for other fluorophores
in phosphorus systems. Photophysical data were collected for
all ligands and complexes in dry degassed tetrahydrofuran to
minimise photobleaching and phosphine oxidation in solu-
tion (Table 1).
The four phosphine ligands 2a/2b and 3a/3b all show a
typical Bodipy profile6 with absorption maxima at either
517/513 nm or 518/512 nm depending on the groups at the
boron centre; changing from diphenyl to dimethyl causes a
hypsochromic shift of the absorption maxima (4–6 nm). The
lowest energy maximum is assigned to the S0–S1 (π–π*) tran-
Fig. 8 View of the molecular structure of 8a (top) and 9a (bottom).
Hydrogen atoms have been omitted for clarity. Selected bond distances
[Å] and angles [°]: 8a – Au–P 2.223(3), Au–Cl1 2.281(3), P–C21 1.816(12),
P–C24 1.817(14), P–C30 1.810(13), C4–N1 1.400(16), N1–B 1.566(17),
B–C42 1.65(2); P–Au–Cl1 177.24(14), C21–P–C24 108.1(6), C21–P–C30
104.7(6), C24–P–C30 103.1(6), Au–P–C21 110.7(4), Au–P–C24 113.5(5),
Au–P–C30 116.0(4). 9a – Au–P 2.2351(13), Au–Cl 2.2875(13), P–C21
1.817(4), P–C36 1.838(5), P–C42 1.845(4), C4–N1 1.390(5), N1–B
1.574(6), B–C24 1.646(7); P–Au–Cl 178.27(5), C21–P–C36 102.2(2),
C21–P–C42 104.0(2), C36–P–C42 109.8(2), Au–P–C21 112.53(15),
Au–P–C36 113.34(16), Au–P–C42 113.90(17).
Table 1 Photophysical data for phosphines 2a/2b, 3a/3b and the group
11 complexes 4a/4b–9a/9ba
Compound λabs (nm) λem (nm) ε (M
−1 cm−1) ΦF
2a 517 534 77 000 0.042
4a (Cu) 518 535 133 000 0.038
6a (Ag) 518 535 151 000 0.036
8a (Au) 519 538 76 000 0.034
2b 513 527 92 000 0.29
4b (Cu) 513 528 167 000 0.29
6b (Ag) 513 528 155 000 0.26
8b (Au) 514 529 74 000 0.20
3a 518 533 77 000 0.073
5a (Cu) 518 534 143 000 0.069
7a (Ag) 518 534 141 000 0.070
9a (Au) 519 536 78 000 0.058
3b 512 526 82 000 0.44
5b (Cu) 512 527 171 000 0.42
7b (Ag) 513 527 157 000 0.43
9b (Au) 514 529 85 000 0.39
aMeasured in dry degassed tetrahydrofuran at room temperature.
Fluorescence quantum yields were measured with respect to
4,4-difluoro-8-phenyl-1,3,5,7-tetramethyl-2,6-diethyl-4-bora-3a,4a-diaza-
s-indacene.36
Fig. 9 Top: absorption spectra of triarylphosphine 2b and its com-
plexes [Cu(2b)2(CH3CN)][PF6] 4b, [Ag(2b)2(hfa)] 6b and [AuCl(2b)] 8b.
Bottom: absorption spectra of aryldialkylphosphine 3b and its com-
plexes [Cu(3b)2(CH3CN)][PF6] 5b, [Ag(3b)2(hfa)] 7b and [AuCl(3b)] 9b. All
measured in dry degassed tetrahydrofuran at room temperature (con-
centrations range from 3.0 × 10−6 to 1.1 × 10−5 M, see ESI†).
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sition for the Bodipy core. All the ligands have typically high
molar absorption coefficients, ranging from 77 000 to 92 000
M−1 cm−1.6 Secondly, a lower intensity, broader absorption
band can be seen between 370 and 385 nm (ε = 3000–10 000
M−1 cm−1), which is attributed to the S0–S2 (π–π*) transition of
the Bodipy core. There are also low-intensity, high-energy
peaks centred between 250–300 nm for the dicyclohexyl deriva-
tives 3a/3b. The absorption spectra for phosphines 2b/3b and
their complexes are given in Fig. 9; the corresponding spectra
for 2a/3a and their complexes is given in the ESI.†
Room-temperature fluorescence of the phosphine ligands
was readily detected, with maxima of 534/527 nm or
533/526 nm, again depending on the boron substituents
(Fig. 10). The Stokes shifts of 14–17 nm are small, which is
common for the Bodipy fluorophore, and suggests that only
small structural changes occur on excitation.6 The fluo-
rescence quantum yields of 2b (0.29) and 3b (0.44) are typically
high for Bodipy molecules and compare well to the parent
Bodipy 10b (0.35, ESI†), which shows the phosphorus donor
does not quench the fluorescence.
This is unusual and, as with our previously reported Bodipy
primary phosphines,15 contradicts several phosphine examples.4
However, it is perhaps to be expected, given that the DFT calcu-
lations (see Fig. 11 and ESI†) show there is no phosphorus
character in the HOMO, HOMO−1 or HOMO−2 for 2a and 3a,
nor in the HOMO or HOMO−1 for 2b and 3b, and that the
energy difference between the HOMO and the first phos-
phorus-containing orbital is 0.9 eV for all the phosphine
ligands (Fig. 11 and ESI†). The quantum yield for 3b is,
perhaps surprisingly, also higher than that of the parent
Bodipy which has no substituents on the meso phenyl ring
(3b = 0.44 and 10b = 0.35). More detailed investigations into a
Bodipy phosphine series could reveal how the quantum yield
is affected by both the electronic and steric nature of the sub-
stituents on the phosphorus. Changing the methyl groups at
the boron atom for phenyl groups severely quenches the fluo-
rescence (compare 2b: ΦF = 0.29 to 2a: ΦF = 0.042), which is
consistent with our previous findings.15 The absorption
spectra of the complexes are very similar to those of the un-
Fig. 10 Top: emission spectra of triarylphosphine 2b and its complexes
[Cu(2b)2(CH3CN)][PF6] 4b, [Ag(2b)2(hfa)] 6b and [AuCl(2b)] 8b. Bottom:
emission spectra of aryldialkylphosphine 3b and its complexes [Cu-
(3b)2(CH3CN)][PF6] 5b, [Ag(3b)2(hfa)] 7b and [AuCl(3b)] 9b. All measured
in dry degassed tetrahydrofuran at room temperature, excitation wave-
length = 485 nm, concentrations range from 1.9 × 10−6 to 4.0 × 10−6 M,
see ESI†).
Fig. 11 Calculated molecular orbital surfaces of the triarylphosphine 2a
(top two rows) and the aryldialkylphosphine 3a (bottom two rows) from
LUMO+1 to HOMO−5.
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coordinated ligands (Fig. 9); wavelengths of the low energy
transition fall in the range 519–512 nm. The corresponding
molar extinction coefficients are large for the copper (4–5) and
silver (6–7) complexes (ε = 133 000–171 000 M−1 cm−1), due to
the presence of two Bodipy ligands; the monodentate gold
complexes (8–9) retain similar values to the free ligands (ε =
74 000–85 000 M−1 cm−1).
The fluorescence spectra of the complexes 4b–9b are dis-
played in Fig. 10. On complexation, the fluorescence quantum
yields are generally retained, with only a slight decrease
observed on descending the group (for instance 2b: ΦF = 0.29,
8b: ΦF = 0.20). The gold species (8–9) have the lowest relative
quantum yields, likely due to the heavy atom effect. Quenching
is less pronounced for the aryldialkylphosphine complexes of 3b
compared to those of the triarylphosphine 2b (Table 1, Fig. 10)
and all three metal complexes of 3b have higher quantum
yields than the parent Bodipy 10b (ΦF = 0.35). It is noteworthy
that Gray et al. reported group 11 complexes which contained
separated azadipyrromethene and triphenylphosphine ligands;
however, the molar extinction coefficient and fluorescence
quantum yields are significantly lower in those cases,
30 000–65 000 M−1 cm−1 and 0.0024–0.0039 respectively.37
Conclusions
The synthesis of fluorescent monodentate triaryl and aryl-
dialkyl tertiary phosphines has been achieved in excellent
yields via the lithiation of the Bodipy aryl bromides 1a/1b, and
subsequent addition of the relevant chlorophosphine. This
route may be transferable to a range of aryl and alkyl chloro-
phosphines and thus could be an excellent route to a library of
new Bodipy tertiary phosphines. The photophysical properties
of the phosphines are intriguing; the fluorescence is not
quenched significantly compared to their precursor and, in
fact, in the case of aryldialkylphosphines 3a and 3b, the emis-
sion is enhanced in comparison to their parent Bodipys 10a
and 10b (see ESI†). The novel phosphines 2a/2b and 3a/3b
readily coordinate to low-oxidation-state coinage metals at
room temperature in nearly quantitative yield; upon coordi-
nation, the fluorescence of the phosphines is not significantly
quenched. These novel ligands and their complexes have
potential applications in medicinal imaging, as the fluorescent
Bodipy functionality will facilitate cell imaging. Several group
11 metal phosphine complexes have shown cytotoxic pro-
perties against several cancer cell lines,8–10 and our novel
derivatives may well display similar attributes. Future work will
focus on their use in diagnostic imaging and therapy.
Experimental
All air- and/or water-sensitive reactions were performed under
a nitrogen atmosphere using standard Schlenk line tech-
niques. Tetrahydrofuran and diethyl ether were dried over
sodium/benzophenone. Dichloromethane and chloroform
were dried over calcium hydride; all solvents were distilled
prior to use. Hexane and pentane were purchased in an anhy-
drous state. Most starting materials were purchased from
Aldrich, Acros Organics, Alfa Aesar or Strem and used as
received. 4,4-Difluoro-8-phenyl-1,3,5,7-tetramethyl-2,6-diethyl-
4-bora-3a,4a-diaza-s-indacene,36 the arylbromides 1a/1b15 and
[AuCl(tht)]38 were prepared according to literature procedures.
Flash chromatography was performed on silica gel from
Fluorochem (silica gel, 40–63 μ, 60 Å, LC301). Thin-layer
chromatography was performed on Fisher aluminium-based
plates with silica gel and fluorescent indicator (254 nm). Infra-
red spectra were recorded on a Varian 800 FT-IR spectrometer
and mass spectrometry was carried out by the EPSRC National
Mass Spectrometry Service Centre, Swansea. 1H, 13C{1H},
31P{1H}, 19F{1H} and 11B{1H} NMR spectra were recorded on a
JEOL Lambda 500 (1H 500.16 MHz) or JEOL ECS-400 (1H
399.78 MHz) spectrometer at room temperature (21 °C) using
the indicated solvent as internal reference, unless specified
otherwise; 1H and 13C shifts were relative to tetramethylsilane,
31P relative to 80% H3PO4,
11B relative to BF3·Et2O and
19F rela-
tive to CFCl3. It is worth noting that, as for dicyclohexylphenyl-
phosphine,39 six unique cyclohexyl carbon signals are seen in
the 13C{1H} NMR spectra for phosphines 3a and 3b and their
respective complexes. The six signals arise as the two cyclo-
hexyl rings are equivalent but the carbon atoms that are sym-
metrically equivalent are diastereotopic; these diastereotopic
carbon atoms are also non-equivalent with respect to P–C
coupling constants.
All calculations were carried out using Spartan 10 soft-
ware.40 Full geometry optimizations of the studied compounds
were performed using density functional theory with a B3LYP/
6-31G* basis set. A vibrational analysis was performed at the
same level to characterize calculated structures as minima.
Absorption spectra were recorded with a Hitachi Model
U-3310 spectrophotometer while fluorescence studies were
recorded with a Hitachi F-4500 fluorescence spectrophoto-
meter. Solvents used for spectroscopic experiments were
spectrophotometric grade. Absorption and emission spectra
were recorded in dry degassed tetrahydrofuran solution at
room temperature. Fluorescence quantum yields were
measured with respect to 4,4-difluoro-8-phenyl-1,3,5,7-tetra-
methyl-2,6-diethyl-4-bora-3a,4a-diaza-s-indacene (ΦF = 0.76,
λabs = 524 nm, λem = 537 nm, ε = 86 000 M
−1 cm−1, tetrahydro-
furan).36 Dyes were excited at 485 nm and excitation slits set to
5 nm.
8-((4-Diphenylphosphino)phenyl)-4,4-diphenyl-1,3,5,7-
tetramethyl-2,6-diethyl-4-bora-3a,4a-diaza-s-indacene (2a)
8-(4-Bromophenyl)-4,4-diphenyl-1,3,5,7-tetramethyl-2,6-diethyl-
4-bora-3a,4a-diaza-s-indacene (0.50 g, 0.87 mmol) was dis-
solved in anhydrous diethyl ether (40 mL) and cooled to
−78 °C. n-BuLi (0.38 mL, 0.96 mmol, 2.5 M in hexane) was
added dropwise over five minutes and the reaction was
warmed to room temperature over 45 min. The solution was
cooled back to −78 °C and chlorodiphenylphosphine
(0.17 mL, 0.96 mmol) was added dropwise. The reaction
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mixture was allowed to warm up to room temperature and was
stirred for a further two hours. It was washed with water and
extracted with diethyl ether (3 × 30 mL). The combined
organic fractions were washed with brine (30 mL) and dried
over magnesium sulfate. The solvent was removed in vacuo to
yield a red/orange solid. The compound was purified using
column chromatography on silica gel (toluene–hexane 2 : 3,
Rf = 0.4) and gave an orange solid (0.50 g, 84%). A sample suit-
able for X-ray crystallographic analysis was obtained from
chloroform–pentane. 1H NMR (400 MHz, CDCl3) δ 7.45–7.41
(m, 7H), 7.40–7.35 (m, 11H), 7.29–7.24 (m, 4H), 7.22–7.19 (m,
2H), 2.26 (q, 3JHH = 7.3 Hz, 4H), 1.82 (s, 6H), 1.44 (s, 6H), 0.94
(t, 3JHH = 7.3 Hz, 6H) ppm;
13C{1H} NMR (100 MHz, CDCl3)
δ 153.0, 150.8 (br), 140.0, 137.9 (d, JCP = 11.5 Hz), 137.3, 136.7
(d, JCP = 10.5 Hz), 135.0, 133.8, 133.6, 133.4, 132.8, 130.6, 129.0,
128.9, 128.6 (d, JCP = 6.7 Hz), 127.1, 125.4, 17.3, 14.7, 14.5,
12.1 ppm; 31P{1H} NMR (162 MHz, CDCl3) δ −5.5 ppm; 11B{1H}
NMR (128 MHz, CDCl3) δ −1.0 ppm; IR (neat): ν˜ = 2958 (w),
1542 (s), 1472 (s), 1396 (s), 1308 (m), 1170 (m), 1143 (m),
1061 (m), 971 (s), 775 (s) cm−1; HRMS (ESI+) exact mass calcd
for C47H47N2B1P1 [M + H]
+ requires m/z 681.3544, found m/z
681.3570 (2.6 ppm).
8-((4-Diphenylphosphino)phenyl)-4,4-dimethyl-1,3,5,7-
tetramethyl-2,6-diethyl-4-bora-3a,4a-diaza-s-indacene (2b)
Prepared in the same manner as for 2a using 0.50 g
(1.11 mmol) of 8-(4-bromophenyl)-4,4-dimethyl-1,3,5,7-tetra-
methyl-2,6-diethyl-4-bora-3a,4a-diaza-s-indacene, 0.49 mL
(1.22 mmol) of n-BuLi (2.5 M in hexane) and 0.22 mL
(1.22 mmol) of chlorodicyclohexylphosphine. The compound
was purified using column chromatography on silica gel
(chloroform–hexane 1 : 5, Rf = 0.3) to yield an orange solid
(0.37 g, 60%). 1H NMR (400 MHz, CDCl3) δ 7.45–7.42 (m, 2H),
7.41–7.35 (m, 10H), 7.34–7.30 (m, 2H), 2.47 (s, 6H), 2.35 (q,
3JHH = 7.3 Hz, 4H), 1.36 (s, 6H), 1.01 (t,
3JHH = 7.3 Hz, 6H), 0.30
(s, 6H) ppm; 13C{1H} NMR (100 MHz, CDCl3) δ 150.6, 139.8,
137.9, 137.8, 136.7 (d, JCP = 11.5 Hz), 133.8, 133.6, 133.5, 132.4,
132.1, 132.0, 128.8, 128.5 (d, JCP = 6.7 Hz), 17.4, 14.7, 14.5,
11.9, 10.4 (br) ppm; 31P{1H} NMR (162 MHz, CDCl3)
δ −5.5 ppm; 11B{1H} NMR (128 MHz, CDCl3) δ −1.9 ppm; IR
(neat): ν˜ = 2924 (w), 2863 (w), 1552 (s), 1455 (m), 1372 (w), 1314
(s), 1170 (s), 1144 (s), 1064 (m), 977 (s) cm−1; HRMS (EI+) exact
mass calcd for C37H43N2B1P1 [M + H]
+ requires m/z 556.3288,
found m/z 556.3294 (1.1 ppm).
8-((4-Dicyclohexylphosphino)phenyl)-4,4-diphenyl-1,3,5,7-
tetramethyl-2,6-diethyl-4-bora-3a,4a-diaza-s-indacene (3a)
Prepared in the same manner as for 2a using 0.50 g
(0.87 mmol) of 8-(4-bromophenyl)-4,4-diphenyl-1,3,5,7-tetra-
methyl-2,6-diethyl-4-bora-3a,4a-diaza-s-indacene, 0.38 mL
(0.96 mmol) of n-BuLi (2.5 M in hexane) and 0.21 mL
(0.96 mmol) of chlorodicyclohexylphosphine. The compound
was purified using column chromatography on silica gel
(dichloromethane–hexane 1 : 4, Rf = 0.3) to yield an orange
solid (0.42 g, 69%). 1H NMR (500 MHz, CDCl3) δ 7.59–7.56
(m, 2H), 7.41–7.33 (m, 6H), 7.23–7.17 (m, 6H), 2.22 (q,
3JHH = 7.8 Hz, 4H), 1.99–1.66 (m, 12H), 1.77 (s, 6H), 1.36–1.02
(m, 10H), 1.33 (s, 6H), 0.90 (t, 3JHH = 7.8 Hz, 6H) ppm,
13C{1H}
NMR (126 MHz, CDCl3) δ 153.1, 150.8 (br), 140.5, 137.6, 135.2,
135.1, 135.0, 134.0, 133.0, 130.8, 128.4 (d, JCP = 7.6 Hz), 127.2,
125.6, 32.2 (d, 1JCP = 11.5 Hz), 30.1 (d,
2JCP = 16.3 Hz), 28.7 (d,
2JCP = 6.7 Hz), 27.3 (d,
3JCP = 12.5 Hz), 27.1 (d,
3JCP = 7.7 Hz),
26.7, 17.5, 14.8, 14.7, 12.1 ppm; 31P{1H} NMR (202 MHz,
CDCl3) δ 2.7 ppm;
11B{1H} NMR (128 MHz, CDCl3) δ −0.7 ppm;
IR (neat): ν˜ = 2925 (m), 2850 (m), 1548 (s), 1474 (m), 1384 (m),
1307 (s), 1168 (s), 1110 (m), 973 (s) cm−1; HRMS (AP+) calcd for
C47H59B1N2P1 [M + H]
+ requires m/z 692.4540, found m/z
692.4560 (2.9 ppm).
8-((4-Dicyclohexylphosphino)phenyl)-4,4-dimethyl-1,3,5,7-
tetramethyl-2,6-diethyl-4-bora-3a,4a-diaza-s-indacene (3b)
Prepared in the same manner as for 2a using 0.50 g
(1.11 mmol) of 8-(4-bromophenyl)-4,4-dimethyl-1,3,5,7-tetra-
methyl-2,6-diethyl-4-bora-3a,4a-diaza-s-indacene, 0.49 mL
(1.22 mmol) of n-BuLi (2.5 M in hexane) and 0.27 mL
(1.22 mmol) of chlorodicyclohexylphosphine. The compound
was purified using column chromatography on silica gel
(chloroform–hexane 1 : 4, Rf = 0.4) to yield an orange solid
(0.39 g, 62%). 1H NMR (400 MHz, CDCl3) δ 7.47 (m, 2H), 7.21
(d, 3JHH = 8.2 Hz, 2H), 2.37 (s, 6H), 2.23 (q,
3JHH = 7.3 Hz, 4H),
1.90–1.56 (m, 12H), 1.90 (s, 6H), 1.30–0.78 (m, 10H), 0.90 (t,
3JHH = 7.3 Hz, 6H), 0.21 (s, 6H) ppm;
13C{1H} NMR (100 MHz,
CDCl3) δ 150.6, 140.2, 137.9, 135.0 (d, JCP = 19.2 Hz), 134.7 (d,
JCP = 19.2 Hz), 133.8, 132.5, 129.1, 128.3 (d, JCP = 7.7 Hz), 32.1
(d, 1JCP = 12.5 Hz), 29.9 (d,
2JCP = 16.3 Hz), 28.7 (d,
2JCP =
6.7 Hz), 27.4 (d, 3JCP = 12.5 Hz), 27.1 (d,
3JCP = 6.7 Hz), 26.7,
17.6, 14.8, 14.4, 11.9, 10.5 (br) ppm; 31P{1H} NMR (162 MHz,
CDCl3) δ 2.8 ppm;
11B{1H} NMR (128 MHz, CDCl3) δ −2.1 ppm;
IR (neat): ν˜ = 2927 (w), 2856 (w), 1551 (s), 1448 (m), 1321 (m),
1171 (s), 1145 (s), 946 (s) cm−1; HRMS (AP+) calcd for
C37H55B1N2P1 [M + H]
+ requires m/z 568.4227, found m/z
568.4226 (0.1 ppm).
[Cu(2a)2(CH3CN)][PF6] (4a)
Tetrakis(acetonitrile)copper(I)hexafluorophosphate (0.027 g,
0.073 mmol) and 8-(4-diphenylphosphine)phenyl)-4,4-diphenyl-
1,3,5,7-tetramethyl-2,6-diethyl-4-bora-3a,4a-diaza-s-indacene
(0.100 g, 0.147 mmol) were added together to anhydrous
dichloromethane (3 mL) and stirred under nitrogen for two
hours. After removal of solvent an orange solid was produced
(0.107 g, 93%). A sample suitable for X-ray crystallographic
analysis was obtained from ethanol–pentane. 1H NMR
(500 MHz, CDCl3) δ 7.51–7.47 (m, 4H), 7.46–7.40 (m, 12H),
7.39–7.32 (m, 20H), 7.28–7.22 (pseudo t, 8H), 7.21–7.16 (m,
4H), 2.20 (q, 3JHH = 7.3 Hz, 8H), 2.19 (s, 3H), 1.77 (s, 12H), 1.34
(s, 12H), 0.88 (t, 3JHH = 7.3 Hz, 12H) ppm;
13C{1H} NMR
(126 MHz, CDCl3) δ 153.7, 150.3 (br), 139.3, 138.9, 134.6,
134.0, 133.9, 133.5, 133.4, 131.8, 131.0, 130.8, 130.5, 130.0,
129.4, 127.3, 125.7, 120.3, 17.7, 14.8, 14.7, 12.3, 2.31 ppm; 31P
{1H} NMR (202 MHz, CDCl3) δ 0.0 (br), −143.6 (septet, 1JPF =
712.6 Hz) ppm; 11B{1H} NMR (162 MHz, CDCl3) δ −1.0 ppm;
IR (neat): ν˜ = 2960 (w), 2925 (w), 2869 (w), 1548 (s), 1473 (m),
Dalton Transactions Paper
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1435 (m), 1397 (m), 1362 (m), 1305 (m), 1263 (w), 1173 (s),
1144 (m), 974 (s) cm−1; HRMS (ESI+) calcd for
C94H92B2N4P2Cu1 [M − C2H3N1]+ requires m/z 1421.6346,
found m/z 1421.6335 (0.8 ppm).
[Cu(2b)2(CH3CN)][PF6] (4b)
Prepared in the same manner as for 4a using 0.034 g
(0.090 mmol) of tetrakis(acetonitrile)copper(I) hexafluoro-
phosphate and 0.100 g (0.180 mmol) of 2b. Yield 0.115 g
(97%). A sample suitable for X-ray crystallographic analysis
was obtained from ethanol–pentane. 1H NMR (500 MHz,
CDCl3) δ 7.48 (m, 5H), 7.39 (m, 12H), 7.30 (m, 11H), 2.46 (s,
12H), 2.28 (q, 3JHH = 7.3 Hz, 8H), 2.14 (s, 3H), 1.26 (s, 12H),
0.96 (t, 3JHH = 7.3 Hz, 12H), 0.28 (s, 12H) ppm;
13C{1H} NMR
(126 MHz, CDCl3) δ 151.2, 140.4, 138.6, 134.1, 133.5, 133.1,
133.0, 131.6, 130.9, 130.8, 129.9, 129.4, 128.7, 120.6, 17.5, 14.8,
14.4, 12.1, 10.5 (br), 2.2 ppm; 31P{1H} NMR (202 MHz, CDCl3)
δ 0.1 (br), −143.6 (septet, 1JPF = 712.6 Hz) ppm; 11B{1H} NMR
(128 MHz, CDCl3) δ −1.8 ppm; IR (neat): ν˜ = 2959 (w), 2925 (w),
2869 (w), 1551 (s), 1471 (m), 1435 (m), 1360 (m), 1320 (s), 1264
(w), 1173 (s), 1145 (s), 1112 (m), 1026 (w), 981 (m), 945 (s)
cm−1; HRMS (ESI+) calcd for C74H84B2N4P2Cu1 [M − C2H3N1]+
requires m/z 1173.5720, found m/z 1173.5927 (0.9 ppm).
[Cu(3a)2(CH3CN)][PF6] (5a)
Prepared in the same manner as for 4a using 0.027 g
(0.072 mmol) of tetrakis(acetonitrile)copper(I) hexafluoro-
phosphate and 0.100 g (0.144 mmol) of 3a. Yield 0.114 g
(97%). A sample suitable for X-ray crystallographic analysis
was obtained from chloroform–pentane. 1H NMR (500 MHz,
CDCl3) δ 7.67 (m, 4H), 7.48–7.34 (m, 12H), 7.25–7.18 (m, 12H),
2.42–2.23 (m, 4H), 2.22 (br, 3H), 2.13 (q, 3JHH = 7.3 Hz, 8H),
1.91–1.61 (m, 16H), 1.76 (s, 12H), 1.47–1.06 (m, 24H), 1.36 (s,
12H), 0.83 (t, 3JHH = 7.3 Hz, 12H) ppm;
13C{1H} NMR
(126 MHz, CDCl3) δ 153.8, 150.2 (br), 140.4, 138.7, 134.9 (m),
134.4, 133.9, 133.4, 130.4, 129.7 (m), 127.3, 126.8 (pseudo t,
JCP = 15.1 Hz), 125.7, 121.9, 31.8 (pseudo t,
1JCP = 10.6 Hz), 29.7
(br), 28.6, 26.8 (pseudo t, 3JCP = 6.8 Hz), 26.6 (pseudo t,
3JCP =
4.8 Hz), 26.2, 17.4, 14.8, 14.7, 12.2, 2.5 ppm; 31P{1H} NMR
(202 MHz, CDCl3) δ 13.4 (br), −143.5 (septet, 1JPF = 712.6 Hz)
ppm; 11B{1H} NMR (128 MHz, CDCl3) δ −0.2 ppm; IR (neat):
ν˜ = 2960 (w), 2929 (w), 2854 (w), 1549 (s), 1475 (m), 1449 (w),
1397 (w), 1362 (w), 1304 (m), 1263 (w), 1173 (s), 1145 (m), 1112
(m), 974 (s) cm−1; HRMS (ESI+) calcd for C94H116B2N4P2Cu1
[M − C2H3N1]+ requires m/z 1445.8224, found m/z 1445.8197
(1.9 ppm).
[Cu(3b)2(CH3CN)][PF6] (5b)
Prepared in the same manner as for 4a using 0.033 g
(0.088 mmol) of tetrakis(acetonitrile)copper(I) hexafluoro-
phosphate and 0.100 g (0.176 mmol) of 3b. Yield 0.117 g
(96%). A sample suitable for X-ray crystallographic analysis
was obtained from chloroform–pentane. 1H NMR (500 MHz,
CDCl3) δ 7.61 (m, 4H), 7.38 (d,
3JHH = 7.3 Hz, 4H), 2.43 (s,
12H), 2.34 (m, 3H), 2.20 (q, 3JHH = 7.3 Hz, 8H), 2.21 (m, 4H),
1.90 (m, 4H), 1.75 (12H), 1.44–1.03 (m, 24H), 1.18 (s, 12H),
0.94 (t, 3JHH = 7.3 Hz, 12H), 0.26 (s, 12H) ppm;
13C{1H} NMR
(126 MHz, CDCl3) δ 151.2, 140.7, 138.4, 134.9, 133.0, 132.9,
129.4, 128.6, 126.6 (pseudo t, JCP = 15.2 Hz), 122.5, 31.8
(pseudo t, 1JCP = 10.6 Hz), 29.7 (br), 28.6, 26.8 (pseudo t,
3JCP =
5.8 Hz), 26.6 (pseudo t, 3JCP = 5.1 Hz), 26.2, 17.4, 14.7, 14.4,
11.9, 10.4 (br), 2.5 ppm; 31P{1H} NMR (202 MHz, CDCl3) δ 12.7
(br), −143.6 (septet, 1JPF = 712.6 Hz) ppm; 11B{1H} NMR
(128 MHz, CDCl3) δ −1.7 ppm; IR (neat): ν˜ = 2959 (w), 2929 (w),
2854 (w), 1552 (s), 1448 (m), 1360 (m), 1320 (s), 1261 (m), 1173
(s), 1146 (s), 1112 (m), 1021 (w), 982 (m), 945 (s) cm−1; HRMS
(ESI+) calcd for C74H108B2N4P2Cu1 [M − C2H3N1]+ requires m/z
1197.7598, found m/z 1197.7583 (1.3 ppm).
[Ag(2a)2(hfa)] (6a)
(1,5-Cyclooctadiene)(hexafluoroacetylacetonato)silver(I) (0.031 g,
0.074 mmol), and 8-(4-diphenylphosphine)phenyl)-4,4-diphenyl-
1,3,5,7-tetramethyl-2,6-diethyl-4-bora-3a,4a-diaza-s-indacene
(0.100 g, 0.147 mmol) were added together to anhydrous
dichloromethane (2 mL) in a darkened flask and stirred at room
temperature under nitrogen for one hour. After removal of the
solvent an orange solid was produced, which was washed with
anhydrous hexane (3 × 5 mL). Yield 0.103 g (87%). A sample
suitable for X-ray crystallographic analysis was obtained from
chloroform–hexane. 1H NMR (500 MHz, CDCl3) δ 7.63–7.55 (br
d, 3JHH = 7.6 Hz, 4H), 7.52–7.45 (m, 12H), 7.43–7.37 (m, 20H),
7.29–7.24 (m, 8H), 7.23–7.18 (m, 4H), 5.70 (br, 1H), 2.40 (q,
3JHH = 7.8 Hz, 8H), 1.80 (s, 12H), 1.35 (s, 12H), 0.91 (t,
3JHH =
7.8 Hz, 12H) ppm; 13C{1H} NMR (126 MHz, CDCl3) δ 175.9 (d,
JCP = 30.7 Hz), 153.6, 150.5 (br), 139.9 (d, JCP = 37.4 Hz), 134.9,
134.4 (d, JCP = 6.7 Hz), 134.2, 133.9, 133.2, 132.8, 131.8, 131.6,
130.6, 130.5, 129.7, 129.1, 127.3, 125.6, 117.9 (q, 1JCF = 288.9
Hz), 86.7, 17.5, 14.8, 14.7, 12.2 ppm; 31P{1H} NMR (202 MHz,
CDCl3) δ 10.2 (br) ppm;
11B{1H} NMR (128 MHz, CDCl3) δ
−1.1 ppm; 19F{1H} NMR (376 MHz, CDCl3) δ −76.6 ppm; IR
(neat): ν˜ = 2966 (w), 2928 (w), 2870 (w), 1662 (m), 1520 (s), 1472
(m), 1434 (m), 1302 (m), 1171 (s), 972 (s) cm−1; HRMS (ESI+)
calcd for C94H92B2N4P2Ag1 [M − (C5H1F6O2)]+ requires m/z
1469.6068, found m/z 1469.6056 (1.6 ppm).
[Ag(2b)2(hfa)] (6b)
Prepared as for 6a using 0.038 g (0.090 mmol) of (1,5-cyclo-
octadiene)(hexafluoroacetylacetonato)silver(I) and 0.100 g
(0.180 mmol) of 2b. Yield 0.103 g (80%). 1H NMR (400 MHz,
CDCl3) δ 7.44–7.23 (m, 28H), 5.90 (br, 1H), 2.44 (s, 12H), 2.29
(q, 3JHH = 7.3 Hz, 8H), 1.24 (s, 12H), 0.96 (t,
3JHH = 7.3 Hz,
12H), 0.27 (s, 12H) ppm; 13C{1H} NMR (100 MHz, CDCl3) δ
175.8 (d, JCP = 30.8 Hz), 151.0, 139.6, 138.9, 134.2 (d, JCP = 17.3
Hz), 133.7 (d, JCP = 17.3 Hz), 133.3, 133.1, 132.7, 132.3 (d, JCP =
23.0 Hz), 130.3, 129.5 (d, JCP = 9.6 Hz), 129.0 (d, JCP = 8.6 Hz),
128.7, 117.9 (q, 1JCF = 290.4 Hz), 88.9, 17.4, 14.6, 14.3, 11.9,
10.4 (br) ppm; 31P{1H} NMR (162 MHz, CDCl3) δ 6.6 (br) ppm;
11B{1H} NMR (128 MHz, CDCl3) δ −2.2 ppm; 19F{1H} NMR
(376 MHz, CDCl3) δ −76.5 ppm; IR (neat): ν˜ = 2963 (w), 2932
(w), 2871 (w), 1660 (m), 1552 (s), 1538 (s), 1436 (m), 1321 (s),
1253 (s), 1172 (s), 1143 (s), 945 (s), 800 (s) cm−1; HRMS (ESI+)
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calcd for C74H84B2N4P2Ag1 [M − (C5H1F6O2)]+ requires m/z
1217.5475, found m/z 1217.5443 (2.5 ppm).
[Ag(3a)2(hfa)] (7a)
Prepared as for 6a using 0.031 g (0.072 mmol) of (1,5-cyclo-
octadiene)(hexafluoroacetylacetonato)silver(I) and 0.100 g
(0.144 mmol) of 3a. Yield 0.110 g (90%). 1H NMR (500 MHz,
CDCl3) δ 7.80–7.90 (m, 4H), 7.42–7.38 (m, 12H), 7.25–7.17 (m,
12H), 5.71 (br, 1H), 2.37–2.01 (m, 8H), 2.19 (q, 3JHH = 7.3 Hz,
8H), 1.89–1.64 (m, 16H), 1.77 (s, 12H), 1.36–1.06 (m, 20H),
1.28 (s, 12H), 0.86 (t, 3JHH = 7.3 Hz, 12H) ppm;
13C{1H} NMR
(126 MHz, CDCl3) δ 175.0 (d, JCP = 30.2 Hz), 153.5, 150.4 (br),
139.5 (d, JCP = 8.6 Hz), 135.4, 134.9, 133.9, 133.7, 133.2, 130.5,
129.1, 127.3, 125.6, 125.2, 118.2 (q, 1JCF = 290.8 Hz), 85.3, 32.6
(br), 29.4 (br), 28.2, 26.9 (br), 26.8 (br), 26.2, 17.4, 14.8, 14.7,
12.0 ppm; 31P{1H} NMR (202 MHz, CDCl3) δ 23.7 (d,
1J107AgP =
453 Hz), 23.7 (d, 1J109AgP = 517 Hz) ppm;
11B{1H} NMR
(128 MHz, CDCl3) δ −1.0 ppm; 19F{1H} NMR (376 MHz, CDCl3)
δ −76.7 ppm; IR (neat): ν˜ = 2928 (w), 2853 (w), 1661 (s), 1548
(s), 1522 (s), 1474 (m), 1303 (m), 1250 (m), 1172 (s), 1133 (s),
973 (s) cm−1; HRMS (ESI+) calcd for C94H116B2N4P2Ag1 [M −
(C5H1F6O2)]
+ requires m/z 1489.7979, found m/z 1489.7998
(1.3 ppm).
[Ag(3b)2(hfa)] (7b)
Prepared as for 6a using 0.037 g (0.090 mmol) of (1,5-cyclo-
octadiene)(hexafluoroacetylacetonato)silver(I) and 0.100 g
(0.176 mmol) of 3b. Yield 0.115 g (90%). A sample suitable for
X-ray crystallographic analysis was obtained from chloroform–
hexane. 1H NMR (500 MHz, CDCl3) δ 7.77 (m, 4H), 7.37 (d,
3JHH = 7.8 Hz, 4H), 5.69 (br, 1H), 2.46 (s, 12H), 2.27 (q,
3JHH =
7.3 Hz, 8H), 2.22–1.69 (m, 20H), 1.34–0.88 (m, 24H), 1.22 (s,
12H), 0.96 (t, 3JHH = 7.3 Hz, 12H), 0.29 (s, 12H) ppm;
13C{1H}
NMR (126 MHz, CDCl3) δ 174.9 (d, JCP = 29.7 Hz), 150.9, 139.8,
139.2, 135.3, 134.5, 133.4, 132.8, 129.0, 128.2, 118.2 (q, 1JCF =
290.8 Hz), 85.2, 32.5 (br), 29.3 (br), 28.2, 27.0 (br), 26.9 (br),
26.2, 17.5, 14.7, 14.4, 11.7, 10.5 (br) ppm; 31P{1H} NMR
(202 MHz, CDCl3) δ 23.9 (d,
1J107AgP = 453 Hz), 23.9 (d,
1J109AgP
= 519 Hz) ppm; 11B{1H} NMR (128 MHz, CDCl3) δ −1.8 ppm;
19F{1H} NMR (376 MHz, CDCl3) δ −76.6 ppm; IR (neat): ν˜ =
2930 (m), 2857 (w), 1663 (m), 1545 (s), 1525 (m), 1448 (m),
1361 (m), 1321 (s), 1251 (m), 1173 (s), 1146 (s), 944 (s) cm−1;
HRMS (ESI+) calcd for C74H108B2N4P2Ag1 [M − (C5H1F6O2)]+
requires m/z 1242.7329, found m/z 1242.7354 (2.0 ppm).
[AuCl(2a)] (8a)
Chloro(tetrahydrothiophene)gold(I) (0.047 g, 0.147 mmol) and
8-(4-diphenylphosphine)phenyl)-4,4-diphenyl-1,3,5,7-tetramethyl-
2,6-diethyl-4-bora-3a,4a-diaza-s-indacene (0.100 g, 0.147 mmol)
were added together to anhydrous dichloromethane (2 mL)
and stirred under nitrogen for 1 hour. After removal of the
solvent an orange/red solid was produced, which was washed
with anhydrous hexane (3 × 5 mL) to remove the tetrahydro-
thiophene. The complex was purified using column chromato-
graphy on silica gel (chloroform–hexane 1 : 1, Rf = 0.4) to yield
an orange solid (0.101 g, 75%). A sample suitable for X-ray
crystallographic analysis was obtained from chloroform–
hexane. 1H NMR (400 MHz, CDCl3) δ 7.68–7.61 (m, 2H),
7.60–7.45 (m, 12H), 7.30–7.28 (m, 4H), 7.18–7.10 (m, 6H), 2.16
(q, 3JHH = 7.3 Hz, 4H), 1.69 (s, 6H), 1.26 (s, 6H), 0.82 (t,
3JHH =
7.3 Hz, 6H) ppm; 13C{1H} NMR (100 MHz, CDCl3) δ 153.7,
149.9 (br), 141.7, 138.2, 134.5, 134.3 (d, JCP = 13.4 Hz), 134.0
(d, JCP = 13.4 Hz), 133.7, 133.3, 132.1 (d, JCP = 2.9 Hz), 130.2,
130.0 (d, JCP = 11.5 Hz), 129.3 (d, JCP = 11.5 Hz), 128.6, 127.9,
127.1, 125.5, 17.3, 14.7, 14.6, 12.2 ppm; 31P{1H} NMR
(202 MHz, CDCl3) δ 33.2 ppm;
11B{1H} NMR (128 MHz, CDCl3)
δ −1.1 ppm; IR (neat): ν˜ = 2962 (w), 1544 (s), 1472 (m), 1435 (s),
1142 (m), 1101 (m), 972 (s) cm−1; HRMS (ESI+) calcd for
C47H46B1N2P1Cl1Au1 [M]
+ requires m/z 912.2960, found m/z
911.2989 (3.2 ppm).
[AuCl(2b)] (8b)
Prepared in the same manner as for 8a using 0.058 g
(0.180 mmol) of chloro(tetrahydrothiophene)gold(I) and
0.100 g (0.180 mmol) of 2b. The complex was purified using
column chromatography on silica gel (dichloromethane–
hexane 2 : 1, Rf = 0.4). Yield 0.129 g (91%).
1H NMR (400 MHz,
CDCl3) δ 7.66–7.58 (m, 2H), 7.57–7.52 (m, 4H), 7.52–7.44 (m,
8H), 2.44 (s, 6H), 2.30 (q, 3JHH = 7.3 Hz, 4H), 1.28 (s, 6H), 0.99
(t, 3JHH = 7.3 Hz, 6H), 0.27 (s, 6H) ppm;
13C{1H} NMR
(100 MHz, CDCl3) δ 151.2, 141.6, 137.9, 134.3 (d, JCP =
13.4 Hz), 134.0 (d, JCP = 13.4 Hz), 133.1, 132.9, 132.1 (d, JCP =
1.9 Hz), 129.9 (d, JCP = 12.4 Hz), 129.3 (d, JCP = 11.5 Hz), 128.6,
128.5, 128.0, 17.4, 14.6, 14.3, 12.0, 10.3 (br) ppm; 31P{1H} NMR
(162 MHz, CDCl3) δ 33.3 ppm;
11B{1H} NMR (128 MHz, CDCl3)
δ −2.0 ppm; IR (neat): ν˜ = 2962 (w), 2926 (w), 2866 (w),
1552 (s), 1436 (m), 1314 (m), 1170 (s), 1101(s), 946 (s) cm−1;
HRMS (AP+) calcd for C37H43B1N2P1Cl1Au1 [M + H]
+ requires
m/z 788.2642, found m/z 788.2627 (1.9 ppm).
[AuCl(3a)] (9a)
Prepared in the same manner as for 8a using 0.046 g
(0.144 mmol) of chloro(tetrahydrothiophene)gold(I) and
0.100 g (0.144 mmol) of 3a. The complex was purified using
column chromatography on silica gel (dichloromethane–
hexane 1 : 1, Rf = 0.5). Yield 0.116 g (87%). A sample suitable
for X-ray crystallographic analysis was obtained from chloro-
form–diethyl ether. 1H NMR (500 MHz, CDCl3) δ 7.89–7.78 (m,
2H), 7.52–7.49 (m, 2H), 7.37–7.30 (m, 4H), 7.25–7.16 (m, 6H),
2.32 (m, 2H), 2.21 (q, 3JHH = 7.3 Hz, 4H), 2.11–2.09 (m, 2H),
1.89–1.63 (m, 8H), 1.77 (s, 6H), 1.43–1.10 (m, 10H), 1.27 (s,
6H), 0.89 (t, 3JHH = 7.3 Hz, 6H) ppm;
13C{1H} NMR (126 MHz,
CDCl3) δ 153.9, 150.3 (br), 141.3 (d, JCP = 2.9 Hz), 138.5, 135.3
(d, JCP = 11.6 Hz), 134.7, 133.9, 133.5, 130.4, 129.7 (d, JCP =
10.6 Hz), 127.3, 125.7, 125.2, 33.5 (d, 1JCP = 34.7 Hz), 29.7 (d,
2JCP = 1.9 Hz), 28.4, 26.5 (d,
3JCP = 5.7 Hz), 26.4 (d,
3JCP =
2.9 Hz), 25.9, 17.4, 14.8, 14.7, 12.2 ppm; 31P{1H} NMR
(202 MHz, CDCl3) δ 51.4 ppm;
11B{1H} NMR (128 MHz, CDCl3)
δ −1.0 ppm; IR (neat): ν˜ = 2926 (w), 2854 (w), 1545 (s),
1473 (m), 1304 (m), 1263 (m), 1172 (s), 1143 (m), 972 (s) cm−1;
HRMS (AP+) calcd for C47H59B1N2P1Au1Cl1 [M + H]
+ requires
m/z 924.3897, found m/z 924.3904 (1.1 ppm).
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[AuCl(3b)] (9b)
Prepared in the same manner as for 8a using 0.056 g
(0.176 mmol) of chloro(tetrahydrothiophene)gold(I) and
0.100 g (0.176 mmol) of 3b. The complex was purified using
column chromatography on silica gel (dichloromethane–
hexane 1 : 1, Rf = 0.4). Yield 0.121 g (86%). A sample suitable
for X-ray crystallographic analysis was obtained from chloro-
form–pentane. 1H NMR (500 MHz, CDCl3) δ 7.78 (m, 2H), 7.47
(m, 2H), 2.44 (s, 6H), 2.30 (q, 3JHH = 7.5 Hz, 4H), 2.09–1.70 (m,
10H), 1.39–0.85 (m, 12H), 1.21 (s, 6H), 0.98 (t, 3JHH = 7.5 Hz,
6H), 0.27 (s, 6H) ppm; 13C{1H} NMR (126 MHz, CDCl3) δ 151.3,
141.6 (d, JCP = 2.8 Hz), 138.2, 135.4 (d, JCP = 11.6 Hz), 133.1 (d,
JCP = 17.3 Hz), 129.6 (d, JCP = 10.6 Hz), 128.6, 125.4, 125.0, 33.5
(d, 1JCP = 34.7 Hz), 29.6 (d,
2JCP = 2.9 Hz), 28.4, 26.5 (d,
3JCP =
6.7 Hz), 26.4 (d, 3JCP = 3.9 Hz), 25.9, 17.5, 14.8, 14.4, 11.9, 10.5
(br) ppm; 31P{1H} NMR (202 MHz, CDCl3) δ 51.6 ppm;
11B{1H}
NMR (128 MHz, CDCl3) δ −2.1 ppm; IR (neat): ν˜ = 2924 (m),
2851 (w), 1552 (s), 1447 (m), 1359 (m), 1324 (s), 1263 (w),
1173 (s), 1147 (s), 945 (s) cm−1; HRMS (EI+) calcd for
C37H53B1N2P1Au1Cl1 [M − H]+ requires m/z 798.3424, found
m/z 798.3426 (0.2 ppm).
X-ray crystallography
Data were collected at 150 K (120 K for 2a) on an Agilent
Technologies Gemini A Ultra diffractometer with MoKα (λ =
0.71073 Å, for 4a, 5a structures A and B, and 9b) or CuKα (λ =
1.54178 Å, for 4b, 6a, and 8a) radiation,41 and on a Crystal
Logics diffractometer equipped with a Rigaku Saturn 724+
detector at beamline I19 of Diamond Light Source using a syn-
chrotron X-ray wavelength of 0.6889 Å (for 2a, 7b, and 9a).42
Selected crystallographic information is given in Table 2.
Absorption corrections were based on multiple and symmetry-
equivalent data; the structures were solved by direct and heavy-
atom methods, and refined on all unique F2 values with appro-
priate constraints and/or restraints in each case, particularly
for the treatment of disordered structural components.43 Un-
identified solvent and/or counter-ion in the structure of the
complex obtained from the attempted recrystallization of 4a was
treated by the Squeeze procedure of PLATON;44 H atoms could
not be observed in difference maps for this relatively low-pre-
cision structure, so it is not clear whether the complex is a
neutral Cu(II) complex with two ethoxide ligands or a cationic
Cu(I) complex with two ethanol ligands and a highly dis-
ordered small anion, though the latter is more likely from the
observed tetrahedral geometry. Further discussion and evi-
dence from spectroscopic data is provided in the ESI.† CCDC
references: 987389 (2a), 987388 (4a), 987387 (4b), 987386 (5a
A), 987385 (5a B), 987390 (6a), 987384 (7b), 987391 (8a),
987383 (9a) and 987382 (9b).
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